Lead sponsor
University of Nottingham
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
0
Active
53
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
1
Trials by status
Completed
1
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its MechanismsBMI 20-27not applicableCompleted8